INTRODUCTION
In response to recent attention to high rates of post-traumatic stress disorder (PTSD) in soldiers returning from Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF), there have been considerable efforts to characterize their burden of mental illness. [1] [2] [3] However, general medical care needs of OEF/OIF veterans with PTSD have not been characterized. Excess burden of medical illness in returning veterans with PTSD is likely. Serious medical comorbidity (cardiovascular disease, chronic pain, etc.) has been documented among veterans of other eras with PTSD. 4 Potential mechanisms include neuroendocrine dysregulation, tissue injury, health risk behaviors, and quality of care. [4] [5] [6] Lack of information about the relationship between PTSD and medical illness in the newest generation of veterans represents a serious gap. First, their deployment experience (e.g., exposure to improvised explosive devices, heavy body armor, etc.) differs from that of veterans of earlier eras. Second, prior studies examining the relationship between PTSD and medical conditions have typically focused on patients with remote trauma exposure. Shifting the focus to recently returned veterans spotlights opportunities for intervention in younger veterans for whom late effects of chronic illness might still be averted.
Women could manifest stress-related consequences of deployment in distinct ways. 7 For example, hormone differences could modulate neuroendocrine stress responses. Occupational duties or sexual trauma exposure during service 8 and family roles after return from war differ by gender, potentially impacting both PTSD severity and health. An understanding of the health needs of this rapidly expanding sector of the armed services is critical. 9 Therefore, we examined whether burden of medical illness is heavier in women and men Veterans Health Administration (VHA) OEF/OIF veteran patients with PTSD than in those without mental illness. Secondary analyses described medical conditions contributing to the burden of illness in women and men with PTSD. 
METHODS

Overview of Study Design and Data Sources
11
We selected a 2-year diagnosis ascertainment window (FY06-FY07) for two reasons. First, we expected this to have better sensitivity for detecting conditions than a 1-year window. Second, since some patients could have joined VHA in late FY06, we wanted to include patients for whom an additional year of data (FY07) was available, i.e., for whom there likely was sufficient opportunity to have identified a diagnosis, if present. A patient was considered to have 1 of the 15 categories of medical conditions if he/she had at least one instance of an ICD9 code falling into that condition category at a face-to-face outpatient visit in FY06 or FY07. E codes (external causes of injury) and V codes (treatments/factors influencing health) were not included as diagnoses.
A patient was considered to have one of the 222 medical conditions if he/she had at least one ICD9 code mapping to that condition associated with a face-to-face outpatient visit in FY06 or FY07. A summary "counter" variable indicated total number of medical conditions, from 0-222 (truncated at 25+).
Other Variables. Sex, age, race/ethnicity, and service-connected disability status came from NPCD (supplemented with OEF/OIF Roster data), year of military separation came from the Roster, and utilization came from clinic type "stop codes" in NPCD. Specifications for stop codes representing face-to-face outpatient visits (i.e., not Telephone Care, Laboratory, or Radiology encounters) and stop codes representing Primary Care are listed in Online Appendices 4 and 5.
Analysis
Since prevalence of medical conditions and PTSD differ by gender, all analyses were gender-stratified. Data are shown for all four "PTSD status" subgroups, but the primary focus was on comparing the PTSD subgroup with the No MHC subgroup within each gender. Sensitivity Analyses. We conducted a series of sensitivity analyses to test stability of core findings to varying assumptions. We repeated analyses examining condition counts in patients with PTSD versus No MHC, varying specific assumptions as follows, while leaving other assumptions unchanged. Sensitivity Analysis 1: To address the possibility that some patients without PTSD (e.g., subthreshold PTSD or non-persistent PTSD) are included in the PTSD group, we required at least one instance of a PTSD diagnosis in FY06 and again in FY07 for a patient to be considered to have PTSD. Sensitivity Analysis 2: To address possible under-detection of PTSD and under-detection of medical conditions among patients who made few visits to VHA (e.g., new users or those receiving most care outside VHA), we limited our cohort to patients who were regular VHA users throughout the study period, i.e., who had ≥2 primary care visits in FY06 and ≥2 primary care visits in FY07. Sensitivity Analysis 3: To address the possibility that some ICD9 codes may be entered erroneously, we required at least two instances of an ICD9 code in FY06-FY07 to qualify for a condition. Sensitivity Analysis 4: To address the possibility that some diagnoses may be coded with E or V codes, we allowed these codes to qualify towards condition counts.
RESULTS
Among the 12,831 OEF/OIF women veterans, 27.3% had PTSD, 7.6% SRD, 17.1% Other MHC, and 48.0% No MHC. Among the 77,727 men, 34.8% had PTSD, 6.1% SRD, 11.9% Other MHC, and 47.1% No MHC. Thus, the majority of these VHA users had an MHC. Table 1 shows characteristics for women and men by PTSD status. Nearly all had used VHA primary care services. The mean number of primary care visits across the 2-year period (FY06-FY07) for women with PTSD vs. No MHC was 6.7 vs. 4.6 (P<0.001), and for men was 4.7 vs. 3.4 (P<0.001).
Burden of Illness
The median number of medical conditions for those with PTSD, SRD, Other MHC, and No MHC was 7.0, 6.0, 6.0, and Table 2 ; the full list is in Online Appendix 2.) Traumatic brain injury (TBI) did not fall in the top 10%, but was common: aggregating the category "organic brain syndromes, coma, brain damage" with the category "intracranial injury," prevalence of diagnosed TBI for patients with PTSD, SRD, Other MHC, and No MHC was 4.5%, 1.2%, 1.3%, and 0.7% for women, and 8.5%, 4.1%, 2.9%, and 1.2% for men, respectively. After age adjustment, all of the 20 most frequent conditions in women/men with PTSD were significantly more common in those with PTSD.
Conditions Common in Patients with PTSD
Sensitivity Analyses
In each sensitivity analysis, burden of illness was higher in women and men with PTSD than in those with No MHC (Online Appendix 3).
COMMENT
We found that, among both women and men OEF/OIF veterans who use VHA, burden of medical illness (measured as a count of diagnosed conditions) is greater for those with PTSD than for those with no mental health conditions. A number of specific medical conditions are more prevalent among women and men with PTSD than among those without MHC, even after adjusting for age. The most frequent conditions among women with PTSD are lumbosacral spine disorders, headache, lower extremity joint disorders, skin disorders, tendonitis/myalgia, dental disorders, allergies, vision defects, acute upper respiratory tract infections, and overweight/obesity. The most frequent conditions among men with PTSD are lumbosacral spine disorders, lower extremity joint disorders, hearing problems, hyperlipidemia, tendonitis/ myalgia, skin disorders, dental disorders, hypertension, sleep disturbance, and other joint disorders.
These findings are aligned with earlier studies, but notable given the younger age and unique war experiences of these veterans. Excess burden of medical illness has been documented in patients with PTSD, 4 whether measured by physiciandiagnosed conditions 15 as in our study or by self-report.
15-17 described the relationship between PTSD and medical conditions by gender. Particular strengths of our study include its focus upon newly returned veterans, evaluation of not only PTSD but also SRD, assessment of gender differences, comprehensive approach to medical condition assessment, reliance upon physician-diagnosed medical conditions, and national scope. Women with PTSD had an even greater burden of medical illness than did men with PTSD, perhaps a factor in women's heavier use of primary care. Leading medical conditions were generally similar in women and men with PTSD, although headache and overweight/obesity ranked higher in women than in men; management of such conditions in women with comorbid PTSD may require novel biopsychosocial approaches to care.
MHCs other than PTSD were also associated with excess burden of medical illness. Concerns about the high rates of PTSD in returning veterans should not detract from attention to the substantial medical care needs of those with other MHCs.
Looking to the future, the need for early intervention is evident. For many of the medical conditions prevalent in veterans with PTSD (e.g., hyperlipidemia, hypertension, obesity), chronic disease management and health behavior interventions reduce risk of adverse long-term outcomes, but are more effective if initiated early in the course of disease. Older veterans in VHA have a heavier burden of medical illness than do their civilian counterparts. 28 By recognizing the excess burden of medical illness in recently returned OEF/OIF veterans and addressing their health care needs, the elderly veterans of tomorrow may enjoy better health and functional status. Study findings need to be interpreted in the context of several caveats. First, PTSD status was determined from ICD9 diagnosis codes. Some without PTSD could have been categorized as having PTSD. However, this is unlikely to occur repeatedly in the medical record, so it is reassuring that the main findings persisted in sensitivity analyses requiring at least two instances of a PTSD diagnosis to qualify as PTSD. A more likely scenario is under-diagnosis of PTSD. We attempted to offset this problem by categorizing PTSD status (PTSD, SRD, Other MHC, No MHC) rather than creating a dichotomous PTSD variable. This allowed us to create a comparison group (No MHC) less likely to be contaminated with true PTSD cases. To the extent that we observed a tendency toward increasing burden of medical illness from PTSD to SRD/Other MHC to No MHC, it appears this strategy may have been successful.
Second, medical conditions were ascertained from ICD9 codes as well. While the use of clinician-diagnosed (rather than self-reported) medical conditions is a strength of the study, under-ascertainment of disease likely occurred for some conditions, especially for under-recognized conditions (e.g., sexual dysfunction). Under-ascertainment of disease could potentially be more common among those with No MHC. For example, if they received more care outside VHA, then providers may have had fewer opportunities to diagnose a medical condition. It is reassuring that the direction of findings did not change in sensitivity analyses when we limited the cohort to regular, frequent users of VHA primary care. Conversely, underascertainment of disease could be more common among those with PTSD (e.g., if the presence of PTSD adversely affects a clinician's ability to attend to other problems during a timepressured visit). 29 This would tend to bias our results toward the null. Over-ascertainment of medical conditions is also possible. While many of the conditions examined in this study (such as hypertension, hyperlipidemia, obesity) are easily confirmed with objective measurements, others represent subjective symptoms. PTSD can be associated with high rates of somatic symptoms. 30 However, regardless of whether they are physiologically or psychologically mediated, somatic symptoms can have a profound adverse effect upon physical health status and quality of life, 31 and thus merit serious attention in primary care settings. For this reason, we chose to include symptoms (formally recorded by clinicians with ICD9 codes) in our assessment of overall burden of medical illness. Since diseases and symptoms that are repeatedly a reason for a patient's visit are likely to be more clinically important, in sensitivity analyses we defined medical conditions more stringently (i.e., requiring that the clinician assigned the patient the same diagnosis at two or more separate visits). Study conclusions did not change, but rates of medical conditions did decrease. This could mean that there was some over-ascertainment of disease using the 1+ diagnosis criterion, that some of the conditions studied were self-limited or intermittent, or that the presence of chronic conditions was not recorded at every visit and thus not detected with the more stringent method. Third, we studied OEF/OIF veteran VHA patients. Findings may not be generalizable to OEF/OIF veterans who do not use VHA, veterans of other eras, or non-veterans.
CONCLUSIONS
Based on these findings, VHA's response to the newest generation of returning veterans with PTSD should account for not only their increased mental health services needs, but also their increased medical services needs. Capacity may need to be augmented for the care of certain conditions, including painful musculoskeletal conditions (e.g., physical therapy, pain clinics), conditions potentially related to health behaviors like obesity (e.g., behavioral medicine, nutrition), hearing problems (e.g., audiology), and gender-specific conditions (e.g., women's health services). Despite the added case complexity associated with presence of co-morbid PTSD, primary care providers will need to fit screening for cardiovascular risk factors (hyperlipidemia, hypertension, smoking) into the visit. Prevalent conditions like sexual dysfunction and sleep problems may require a coordinated effort between medical and mental health providers. Recent re-organization of VHA's health care delivery system (e.g., patient-centered medical home, mental health providers embedded in primary care settings, tele-mental health initiatives, case management) may prove particularly beneficial for veterans with comorbid PTSD and medical illness. More work is needed to clarify whether the intensity and types of medical services currently received by OEF/OIF veterans with PTSD are well matched to the specific conditions common in this cohort, and whether medical treatments need closer integration with mental health services for this special population newly returned from military service.
